首页 | 本学科首页   官方微博 | 高级检索  
检索        

Protective effect of icaritin on focal cerebral ischemic–reperfusion mice
作者姓名:Cheng-hong Sun  Li-hong Pan  Jian Yang  Jing-chun Yao  Bing-bing Li  Yu-jun Tan  Gui-min Zhang  Ying Suna
作者单位:a. State Key Laboratory of Generic Manufacture Technology of Chinese Traditional Medicine, Linyi 273400, China; b. Linyi Key Laboratory for Immunopharmacology and Immunotoxicology of Natural Medicine, Linyi 273400, China; c. Center for New Drug Pharmacology, Lunan Pharmaceutical Group Corporation, Linyi 273400, China,a. State Key Laboratory of Generic Manufacture Technology of Chinese Traditional Medicine, Linyi 273400, China; b. Linyi Key Laboratory for Immunopharmacology and Immunotoxicology of Natural Medicine, Linyi 273400, China; c. Center for New Drug Pharmacology, Lunan Pharmaceutical Group Corporation, Linyi 273400, China,a. State Key Laboratory of Generic Manufacture Technology of Chinese Traditional Medicine, Linyi 273400, China; b. Linyi Key Laboratory for Immunopharmacology and Immunotoxicology of Natural Medicine, Linyi 273400, China; c. Center for New Drug Pharmacology, Lunan Pharmaceutical Group Corporation, Linyi 273400, China,a. State Key Laboratory of Generic Manufacture Technology of Chinese Traditional Medicine, Linyi 273400, China; b. Linyi Key Laboratory for Immunopharmacology and Immunotoxicology of Natural Medicine, Linyi 273400, China; c. Center for New Drug Pharmacology, Lunan Pharmaceutical Group Corporation, Linyi 273400, China,a. State Key Laboratory of Generic Manufacture Technology of Chinese Traditional Medicine, Linyi 273400, China; b. Linyi Key Laboratory for Immunopharmacology and Immunotoxicology of Natural Medicine, Linyi 273400, China; c. Center for New Drug Pharmacology, Lunan Pharmaceutical Group Corporation, Linyi 273400, China,a. State Key Laboratory of Generic Manufacture Technology of Chinese Traditional Medicine, Linyi 273400, China; b. Linyi Key Laboratory for Immunopharmacology and Immunotoxicology of Natural Medicine, Linyi 273400, China; c. Center for New Drug Pharmacology, Lunan Pharmaceutical Group Corporation, Linyi 273400, China,a. State Key Laboratory of Generic Manufacture Technology of Chinese Traditional Medicine, Linyi 273400, China; b. Linyi Key Laboratory for Immunopharmacology and Immunotoxicology of Natural Medicine, Linyi 273400, China,a. State Key Laboratory of Generic Manufacture Technology of Chinese Traditional Medicine, Linyi 273400, China
摘    要:Objective: To investigate the protective effects of icaritin(ICT),one of the active ingredients in Epimedii Folium,on mouse model of cerebral ischemia-reperfusion(I/R)in vivo.Methods: ICR mice were subjected to an 1 h transient middle cerebral artery occlusion(MCAO)and followed by 24 h of reperfusion.Neurological deficits,infarct volume,brain edema and survive rate were measured,respectively.The levels of brain IL-1β,TNF-α,ROS and DNA-binding activity of NF-κB p65 were measured by ELISA kits.The levels of malondialdehyde(MDA)and activities of superoxide dismutase(SOD)were detected by spectrophotometry,and the release of nitric oxide(NO)were detected by Griess kit.Results: ICT markedly reduced the neurological deficit scores,brain edema,infarct volume and increased the survival rate of the cerebral I/R mice.The expression of IL-1 β,TNF-α,NO,MDA and DNA-binding activity of NF-κB p65 were significantly inhibited by ICT,while the activity of SOD were up-regulated at the same time.Conclusion: ICT possessed significant neuroprotective effects in cerebral I/R mice,which might be related to prevent neuroinflammatory and oxidative damage.

收稿时间:11 May 2017

Protective effect of icaritin on focal cerebral ischemic-reperfusion mice
Cheng-hong Sun,Li-hong Pan,Jian Yang,Jing-chun Yao,Bing-bing Li,Yu-jun Tan,Gui-min Zhang,Ying Suna.Protective effect of icaritin on focal cerebral ischemic-reperfusion mice[J].Chinese Herbal Medicines,2018,10(1):40-45.
Authors:Cheng-hong Sun  Li-hong Pan  Jian Yang  Jing-chun Yao  Bing-bing Li  Yu-jun Tan  Gui-min Zhang  b and Ying Suna
Institution:1. State Key Laboratory of Generic Manufacture Technology of Chinese Traditional Medicine, Linyi 276000, China\n;2. Linyi Key Laboratory for Immunopharmacology and Immunotoxicology of Natural Medicine, Linyi 276000, China\n;3. Center for New Drug Pharmacology, Lunan Pharmaceutical Group Corporation, Linyi 276000, China
Abstract:

Objective

To investigate the protective effects of icaritin (ICT), one of the active ingredients in Epimedii Folium, on mouse model of cerebral ischemia-reperfusion (I/R) in vivo.

Methods

ICR mice were subjected to an 1?h transient middle cerebral artery occlusion (MCAO) and followed by 24?h of reperfusion. Neurological deficits, infarct volume, brain edema and survive rate were measured, respectively. The levels of brain IL-1β, TNF-α, ROS and DNA-binding activity of NF-κB p65 were measured by ELISA kits. The levels of malondialdehyde (MDA) and activities of superoxide dismutase (SOD) were detected by spectrophotometry, and the release of nitric oxide (NO) were detected by Griess kit.

Results

ICT markedly reduced the neurological deficit scores, brain edema, infarct volume and increased the survival rate of the cerebral I/R mice. The expression of IL-1β, TNF-α, NO, MDA and DNA-binding activity of NF-κB p65 were significantly inhibited by ICT, while the activity of SOD were up-regulated at the same time.

Conclusion

ICT possessed significant neuroprotective effects in cerebral I/R mice, which might be related to prevent neuroinflammatory and oxidative damage.
Keywords:brain edema  brain infarct  icaritin  focal cerebral ischemic–reperfusion  neuroinflammation  oxidative damage
本文献已被 CNKI ScienceDirect 等数据库收录!
点击此处可从《中草药(英文版)》浏览原始摘要信息
点击此处可从《中草药(英文版)》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号